Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
Authors
Keywords
Cancer risk factors, Meta-analysis, Publication ethics, Breast cancer, Genetic epidemiology, Ethnicities, Genome-wide association studies, T cells
Journal
PLoS One
Volume 11, Issue 3, Pages e0152448
Publisher
Public Library of Science (PLoS)
Online
2016-04-01
DOI
10.1371/journal.pone.0152448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese
- (2015) Jie Ge et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1Gene Polymorphisms in Iranian Patients With Colorectal Cancer
- (2015) Ali Reza Yousefi et al. Labmedicine
- Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer
- (2014) Hao Qiu et al. CLINICAL BIOCHEMISTRY
- Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma
- (2014) Myoung Jae Kang et al. Translational Oncology
- Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: A case–control study
- (2012) Süleyman Bayram et al. GENE
- Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer
- (2012) Zahra Mojtahedi et al. GENE
- PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China
- (2011) Zhang Hua et al. BREAST CANCER RESEARCH AND TREATMENT
- Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model
- (2011) David M. Foureau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1, gender, and autoimmunity
- (2010) Ravi K. Dinesh et al. AUTOIMMUNITY REVIEWS
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
- (2010) Q. Zhou et al. BLOOD
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
- Program death 1 (PD1) haplotyping in patients with breast carcinoma
- (2010) Mohammad Reza Haghshenas et al. MOLECULAR BIOLOGY REPORTS
- Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma
- (2009) R. Karim et al. CLINICAL CANCER RESEARCH
- Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer
- (2009) Emma L. Ivansson et al. GYNECOLOGIC ONCOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search